ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

ROCKET PHARMACEUTICALS, INC.

RCKT

$2.21

-$0.09 (-3.91%)

Price as of Oct 14, 2026 20:24 UTC

340 M

Market Cap (Small Cap)

9%

IV Rank

134.3%

Implied Volatility

Nov 04

Next Earnings

Technical Signals as of Oct 13
Bearish
1 of 7

Trend

  • Above 20-day average $2.76
  • Above 50-day average $3.08
  • Above 200-day average $3.42 · -32.7%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) Down · 15d ago

Volume

  • Elevated volume 1.7x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.00

Bullish skew

Implied Volatility

134.3%

0% percentile

IV vs Realized

Options rich

30d HV 62.7%

Options Heat Map

Delta-risk grid for RCKT options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

2 buys 49 sells
Date Insider Title Type Shares Value Since Trade
Sep 11, 2026 Wilson Martin Sell 75,364 $256,464 -32.4%
Aug 18, 2026 Wilson Martin Sell 631 $2,133 -32.0%
Aug 18, 2026 Shah Gaurav Sell 2,293 $7,753 -32.0%
Aug 13, 2026 Wilson Martin Sell 3,493 $11,810 -32.0%
Aug 13, 2026 Shah Gaurav Sell 2,837 $9,592 -32.0%
Aug 11, 2026 Stevens Christopher James Sell 36,658 $128,266 -34.3%
Aug 11, 2026 Chaudhuri Sarbani Sell 4,701 $16,449 -34.3%
Aug 03, 2026 Stevens Christopher James Grant 101,428 $0 -32.6%
Aug 03, 2026 Stevens Christopher James Grant 73,313 $0 -32.6%
Aug 03, 2026 SOUTHWELL DAVID P Other 150,000 $0 -32.6%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 10, 2026 Q2 2026 $0.25
Aug 05, 2026 Q2 2026 $0.38
Mar 31, 2026 Q1 2026 -$0.42 -$0.42 -1.2% Miss
Dec 31, 2025 Q4 2025 -$0.46 -$0.38 +17.8% Beat
Sep 30, 2025 Q3 2025 -$0.52 -$0.45 +12.6% Beat
Jun 30, 2025 Q2 2025 -$0.57 -$0.59 -3.9% Miss

Track RCKT with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for RCKT and your entire portfolio.